Martine Pennetier

Cas clinique illustré autour d’un patient atteint d’un syndrome inflammatoire multisystémique pédiatrique

Camille Le Guen, Estelle Leroy, Martine Pennetier, Elise Launay et autres

fr (code pays fourni par la source)

Real-World Experience with a New Human Fibrinogen Concentrate (Fibryga®) in France for the Treatment of Bleeding Episodes and Surgical Prophylaxis

François Stéphan, L. Gutermann, Martine Pennetier, Stephanie Bourget et autres

Introduction: Fibrinogen deficiency can be either congenital, or acquired due to situations such as trauma, excessive surgical bleeding, or post-partum hemorrhage (PPH). Transfusion of human fibrinogen concentrate (HFC) can correct this deficiency, preventing hemorrhage and excessive blood loss. This study aimed to …

fr, us (code pays fourni par la source)

Use of a new human fibrinogen concentrate (FIBRYGA®) In cardiac surgeries: first real-world experience in France based on temporary authorization

François Stéphan, L. Gutermann, Martine Pennetier, Sarah Djabarouti et autres

fr (code pays fourni par la source)

Management of previously untreated patients with severe haemophilia A preferentially treated with recombinant factor VIII products: Two French centres' real‐life experience

Nicolas Drillaud, Antoine Babuty, Lucia Rugeri, Marc Fouassier et autres

fr (code pays fourni par la source)

DI-089 The mothif study or how to implement a pharmacist network in haemostasis to assess the costs of treatment in haemophilia a and b

Valérie Horvais, Martine Pennetier, G. Chapelle, A Athouel et autres

This abstract was published in error and withdrawn at the author’s request.

fr (code pays fourni par la source)

The mothif study. Costs of Clotting Factors In Haemophilia A And B: A Review From The Berhlingo Database In Seven Comprehensive Health Care Centres In France

Valérie Horvais, Martine Pennetier, G. Chapelle, A Athouel et autres

fr (code pays fourni par la source)

FRENCH MULTIDISCIPLINARITY NETWORK ON IMMUNOLOGIC DISORDERS OBSERVIG: PHARMACEUTICAL CONTRIBUTIONS

Martine Pennetier

Étude prospective, observationnelle de la sécurité d’emploi de la 3,4-diaminopyridine base

A. Chincholle, E. Rousselet, A. Trainaud, Anne Chiffoleau et autres

fr (code pays fourni par la source)

Efficacy of lenalidomide plus dexamethasone in patients older than 75 years with relapsed multiple myeloma

Cyrille Touzeau, Nicolas Pétur Blin, Aline Clavert, Virginie Roland et autres

Few data are available on the efficacy of the combination of lenalidomide plus dexamethasone (Len/Dex) in very elderly patients above 75 years of age with relapsed multiple myeloma (MM). We report here a single-center series of 45 consecutive patients aged 75 years …

fr (code pays fourni par la source)

Thrombopénie Induite à l'Héparine et évaluation des pratiques professionnelles

J. Connault, Marc Trossaërt, Martine Pennetier, Dominique El Kouri et autres

fr (code pays fourni par la source)